Nihon Kohden Corp

6849
stockHealthcareHealth Care Equipment
$6/day into 6849 since 2015 would be worth $17,244 today — 1.0× the money.
Try your own number →

Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The company also provides patient monitors such as central monitors, bedside monitors, wireless monitors, remote access software and other equipment, clinical information systems, and electrodes and sensors. In addition, it offers Defibrillators, AEDs, ventilators, pacemakers, anesthesia machines, cochlear implants, automated chest compression devices, AED pads, batteries, and ablation catheters; hematology analyzers, clinical chemistry analyzers, ultrasound diagnostic equipment and others, consumables, including test reagents, and installation and maintenance services. Further, it is involved in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.

Description from Yahoo Finance
Full profile on Yahoo Finance →

If you'd bought from year…

Same habit, different start year. Each row shows what a constant habit's worth of 6849-T would be worth today, had you started buying at that point in the asset's history.

Started$6/day$6/day coffee$42/wk$42/week coffee
Year 1 (2001) — listing
$184,366
4.9×
$263,572
4.7×
Year 6 (2006)
$64,871
2.2×
$96,136
2.2×
Year 11 (2011)
$32,715
1.4×
$48,626
1.4×
Year 16 (2016)
$15,374
1.0×
$22,725
1.0×
Year 21 (2021)
$6,951
0.9×
$10,403
0.9×

Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.

Popular scenarios with 6849

For illustration only — not investment advice. Past performance is not indicative of future results.